---
title: Statins did not reduce the frequency of exacerbations in individuals with COPD
  and cardiovascular comorbidities in the COSYCONET cohort
date: '2024-05-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38750572/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240516181522&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: These findings complement the existing literature and may
  suggest that even in patients with COPD, cardiovascular comorbidities and a statin
  therapy that targets these comorbidities, the effects of statins on exacerbation
  risk are either negligible or more subtle than a reduction in exacerbation ...'
disable_comments: true
---
CONCLUSION: These findings complement the existing literature and may suggest that even in patients with COPD, cardiovascular comorbidities and a statin therapy that targets these comorbidities, the effects of statins on exacerbation risk are either negligible or more subtle than a reduction in exacerbation ...